Harry Finch
Keine laufenden Positionen mehr
Aktive Positionen von Harry Finch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pulmagen Therapeutics (Inflammation) Ltd. | Direktor/Vorstandsmitglied | - | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Harry Finch
Ehemalige bekannte Positionen von Harry Finch
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
C4X DISCOVERY HOLDINGS PLC | Direktor/Vorstandsmitglied | 03.09.2014 | 18.01.2022 |
Independent Dir/Board Member | 03.09.2014 | 18.01.2022 | |
Glaxo Wellcome Plc | Corporate Officer/Principal | - | - |
Pulmagen Therapeutics (Holdings) Ltd. | Direktor/Vorstandsmitglied | - | - |
Pulmagen Therapeutics (Asthma) Ltd.
Pulmagen Therapeutics (Asthma) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pulmagen Therapeutics LLP, Pulmagen Therapeutics (Asthma) Ltd. provides research and development services of natural sciences & engineering. The company is based in Slough, UK. | Direktor/Vorstandsmitglied | - | - |
Glaxo Wellcome, Inc. | Corporate Officer/Principal | - | - |
GSK PLC | Corporate Officer/Principal | - | - |
Ciba-Geigy Corp. | Corporate Officer/Principal | - | - |
░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Harry Finch
The University of Manchester | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 12 |
Vereinigte Staaten | 3 |
Israel | 2 |
Operativ
Director/Board Member | 8 |
Corporate Officer/Principal | 6 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 10 |
Commercial Services | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GSK PLC | Health Technology |
C4X DISCOVERY HOLDINGS PLC | Health Technology |
Private Unternehmen | 11 |
---|---|
Ciba-Geigy Corp. | Health Technology |
Glaxo Wellcome Plc | Health Technology |
RiboTargets Ltd. | Health Technology |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
Glaxo Wellcome, Inc. | Health Technology |
C4X Discovery Ltd.
C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Pulmagen Therapeutics LLP
Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Health Technology |
Pulmagen Therapeutics (Inflammation) Ltd. | |
Pulmagen Therapeutics (Holdings) Ltd. | Commercial Services |
Pulmagen Therapeutics (Asthma) Ltd.
Pulmagen Therapeutics (Asthma) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pulmagen Therapeutics LLP, Pulmagen Therapeutics (Asthma) Ltd. provides research and development services of natural sciences & engineering. The company is based in Slough, UK. | Commercial Services |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Harry Finch
- Erfahrung